Celldex Therapeutics, Inc
Symbol: CLDX (NASDAQ)
25.08
▲ (0.49%) 0.122
Company Description:
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Key Stats
- Today's Open: $25.18
- Today's High: $25.474
- Today's Low: $24.747
- Today's Volume: 495.87K
- Yesterday Close: $24.96
- Yesterday High: $25.29
- Yesterday Low: $24.18
- Yesterday Volume: 1.53M
- Last Min Volume: 1.99K
- Last Min High: $25.09
- Last Min Low: $25.09
- Last Min VWAP: $25.09
Company Profile
- Name: Celldex Therapeutics, Inc
- Website: https://www.celldex.com
- Listed Date: 1986-05-15
- Location: HAMPTON, NJ
- Market Status: Active
- CIK Number: 0000744218
- SIC Code: 2835
- SIC description: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- Market Cap: $1.66B
- Round Lot: 100
- Outstanding Shares: 66.41M
- Asset Type: CS
RECENT FILINGS FOR CLDX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-19 | 8-K | View |
| 2025-08-15 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-10 | SCHEDULE 13G | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
Latest News on CLDX